Harmony Biosciences
HRMY
HRMY
317 hedge funds and large institutions have $1.86B invested in Harmony Biosciences in 2025 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 120 increasing their positions, 108 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
11% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 108
8% more funds holding
Funds holding: 294 → 317 (+23)
4.51% more ownership
Funds ownership: 82.36% → 86.87% (+4.5%)
Holders
317
Holding in Top 10
4
Calls
$11.9M
Puts
$7.67M
Top Buyers
| 1 | +$30.9M | |
| 2 | +$16.4M | |
| 3 | +$15.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$10.1M |
Top Sellers
| 1 | -$37.8M | |
| 2 | -$24.1M | |
| 3 | -$9.33M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$8.41M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.77M |
